|
248 Companies |
|
339 Products |
|
339 Products |
|
149 Mechanisms of Action |
|
22 Trials |
|
5600 News |
|
| «12345678910111213...109110» |
- | Trial completion: P2P EIA RCT: Peer to Peer Mentoring For Individuals With Early Inflammatory Arthritis: An Effectiveness Study (Pilot RCT)- Peer Mentor Training (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=20, Completed, Sponsor: Sunnybrook Health Sciences Centre
Recruiting --> Completed
- | Trial completion: P2P EIA RCT: Peer to Peer Mentoring For Individuals With Early Inflammatory Arthritis: An Effectiveness Study (Pilot RCT)- Peer Mentoring Program (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=40, Completed, Sponsor: Sunnybrook Health Sciences Centre
Recruiting --> Completed Recruiting --> Completed
- ||||||| Humia (hyaluronic acid) / Huons
Trial completion: A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee (clinicaltrials.gov) - Apr 12, 2018
P3, N=232, Completed, Sponsor: Huons Co.,Ltd.
Recruiting --> Completed Recruiting --> Completed
- ||||| Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment change, Combination therapy: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-na (clinicaltrials.gov) - Apr 10, 2018
P3, N=359, Completed, Sponsor: UCB Pharma
Recruiting --> Completed N=880 --> 359
- tibulizumab (ZB-106) / Zura Bio
Trial primary completion date: A Study of LY3090106 in Participants With Sj (clinicaltrials.gov) - Apr 10, 2018
P1, N=32, Active, not recruiting, Sponsor: Eli Lilly and Company
N=880 --> 359 Trial primary completion date: Mar 2018 --> Jul 2018
- | Trial completion: Joint Replacement or Interpositional Arthroplasty for CMC1 Arthritis, a Prospective Trial (clinicaltrials.gov) - Apr 10, 2018
P=N/A, N=40, Completed, Sponsor: Oslo University Hospital
Trial primary completion date: Mar 2018 --> Jul 2018 Active, not recruiting --> Completed
- | Trial completion, Phase classification, Trial primary completion date: Detecting and Addressing Preclinical Disability (clinicaltrials.gov) - Apr 9, 2018
P, N=148, Completed, Sponsor: McMaster University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017
- | Trial completion, Trial completion date, Trial primary completion date: Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty (clinicaltrials.gov) - Apr 9, 2018
P4, N=100, Completed, Sponsor: William Beaumont Hospitals
Active, not recruiting --> Completed | Phase classification: PN/A --> P | Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Completed | Trial completion date: Feb 2018 --> Jun 2017 | Trial primary completion date: Feb 2018 --> May 2017
- | Trial completion date, Trial primary completion date, HEOR, Surgery: Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients (clinicaltrials.gov) - Apr 9, 2018
P1, N=50, Recruiting, Sponsor: Johns Hopkins University
Recruiting --> Completed | Trial completion date: Feb 2018 --> Jun 2017 | Trial primary completion date: Feb 2018 --> May 2017 Trial completion date: Feb 2018 --> Jul 2018 | Trial primary completion date: Feb 2018 --> May 2018
- | Phase classification, Enrollment change, MRI: Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imaging for Identifying Poor Prognosis in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Apr 6, 2018
P, N=10, Completed, Sponsor: Optimus Clinical Research
Trial completion date: Feb 2018 --> Jul 2018 | Trial primary completion date: Feb 2018 --> May 2018 Phase classification: P=N/A --> P | N=20 --> 10
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Andosan-RA: Effect of Andosan in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Apr 6, 2018
P=N/A, N=10, Completed, Sponsor: Egil Johnson
Phase classification: P=N/A --> P | N=20 --> 10 Recruiting --> Completed | N=15 --> 10 | Trial completion date: May 2017 --> Apr 2018 | Trial primary completion date: Dec 2016 --> Mar 2018
- | Trial completion: Comparing Conservative Therapies for the Alleviation of Knee Pain in Knee Osteoarthritis (clinicaltrials.gov) - Apr 6, 2018
P4, N=50, Completed, Sponsor: Queen's University
Recruiting --> Completed | N=15 --> 10 | Trial completion date: May 2017 --> Apr 2018 | Trial primary completion date: Dec 2016 --> Mar 2018 Recruiting --> Completed
- | Phase classification: TKA Using Patient-Specific Instrumentation (clinicaltrials.gov) - Apr 6, 2018
P=N/A, N=0, Withdrawn, Sponsor: Queen's University
Recruiting --> Completed Phase classification: P4 --> P=N/A
- | Phase classification, Enrollment change: Genetic Analysis of Psoriasis and Psoriatic Arthritis (clinicaltrials.gov) - Apr 6, 2018
P, N=2653, Completed, Sponsor: National Cancer Institute (NCI)
Phase classification: P4 --> P=N/A Phase classification: P=N/A --> P | N=5000 --> 2653
- | Phase classification: The Strong Brain Study (clinicaltrials.gov) - Apr 5, 2018
P, N=18, Completed, Sponsor: University of Florida
Phase classification: P=N/A --> P | N=5000 --> 2653 Phase classification: P=N/A --> P
- | Trial completion, HEOR: Joint Fitness: Exercise and Body Composition in Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Apr 5, 2018
P=N/A, N=33, Completed, Sponsor: Johns Hopkins University
Phase classification: P=N/A --> P Recruiting --> Completed
- | Trial completion, Phase classification, Trial completion date, Trial primary completion date: Fibrocytes in Early and Longstanding Rheumatoid Arthritis (clinicaltrials.gov) - Apr 5, 2018
P, N=60, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed Recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: Jan 2019 --> Apr 2018 | Trial primary completion date: Jan 2018 --> Apr 2018
- ||| Trial completion: OSIRIS: InterventiOnal Study of Bone and Joint Infections Related Gut dysbiosIS (clinicaltrials.gov) - Apr 5, 2018
P=N/A, N=62, Completed, Sponsor: MaaT Pharma
Recruiting --> Completed | Phase classification: PN/A --> P | Trial completion date: Jan 2019 --> Apr 2018 | Trial primary completion date: Jan 2018 --> Apr 2018 Active, not recruiting --> Completed
- ||||||| TPX-100 / American Regent
Trial completion, Phase classification, Trial completion date: A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees (clinicaltrials.gov) - Apr 5, 2018
P, N=54, Completed, Sponsor: OrthoTrophix, Inc
Active, not recruiting --> Completed Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Trial completion date: Nov 2017 --> Mar 2018
- ||| Trial completion, Phase classification, Trial completion date, Trial primary completion date: A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=160, Completed, Sponsor: Johnson & Johnson Medical (Suzhou) Ltd.
Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Trial completion date: Nov 2017 --> Mar 2018 Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Sep 2017 --> Jan 2018 | Trial primary completion date: Jul 2017 --> Dec 2017
- | Trial completion, Enrollment change, Trial primary completion date: Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial (clinicaltrials.gov) - Apr 2, 2018
P=N/A, N=55, Completed, Sponsor: Lakehead University
Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Sep 2017 --> Jan 2018 | Trial primary completion date: Jul 2017 --> Dec 2017 Recruiting --> Completed | N=100 --> 55 | Trial primary completion date: Sep 2017 --> Feb 2018
- | Trial completion date, Trial primary completion date: Massage Therapy in Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Mar 31, 2018
P=N/A, N=30, Recruiting, Sponsor: McGill University Health Center
Recruiting --> Completed | N=100 --> 55 | Trial primary completion date: Sep 2017 --> Feb 2018 Trial completion date: Dec 2017 --> Jan 2019 | Trial primary completion date: Dec 2017 --> Jan 2019
- ||||||||| Phase classification, Trial completion date, Trial termination, Trial primary completion date: A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx (clinicaltrials.gov) - Mar 31, 2018
P, N=20, Terminated, Sponsor: Regenerative Sciences, LLC
Trial completion date: Dec 2017 --> Jan 2019 | Trial primary completion date: Dec 2017 --> Jan 2019 Phase classification: P=N/A --> P | Trial completion date: Dec 2018 --> Mar 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Mar 2018; Terminated early for poor study design.
- | NN1213 / Novo Nordisk
Phase classification: Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases (clinicaltrials.gov) - Mar 30, 2018
P, N=140, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Phase classification: P=N/A --> P | Trial completion date: Dec 2018 --> Mar 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Mar 2018; Terminated early for poor study design. Phase classification: P=N/A --> P
- Enrollment change: Comparing X-3 To N2vac Polyethylene With the Triathlon Total Knee System (clinicaltrials.gov) - Mar 30, 2018
P4, N=0, Withdrawn, Sponsor: Dalhousie University
Phase classification: P=N/A --> P N=384 --> 0
- ||||||| Trial completion, Phase classification, Enrollment change: Epidemiology of Osteoarthritis (OA) Pain (clinicaltrials.gov) - Mar 30, 2018
P, N=86, Completed, Sponsor: Northwestern University
N=384 --> 0 Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=60 --> 86
- Trial primary completion date: Regenexx (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Regenerative Sciences, LLC
Active, not recruiting --> Completed | Phase classification: PN/A --> P | N=60 --> 86 Trial primary completion date: Dec 2017 --> Jun 2018
- | Trial completion date, Trial primary completion date: PRESSRA: The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=50, Suspended, Sponsor: Johns Hopkins University
Trial primary completion date: Dec 2017 --> Jun 2018 Trial completion date: Dec 2017 --> Jun 2018 | Trial primary completion date: Dec 2017 --> Jun 2018
- | Enrollment change, Trial termination: Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=10, Terminated, Sponsor: Rita Merman
N=50 --> 10 | Recruiting --> Terminated; The computer is crushed and all data is lost (IT was not able to recover it. Last data was collected 6.17.14)
- ||||||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion: CIMAX: A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (clinicaltrials.gov) - Mar 30, 2018
P, N=680, Completed, Sponsor: UCB Biopharma S.P.R.L.
Last data was collected 6.17.14) Active, not recruiting --> Completed
- ||||||| Trial completion, Phase classification, Adherence: APRim: Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis (clinicaltrials.gov) - Mar 30, 2018
P, N=471, Completed, Sponsor: Nordic Pharma SAS
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: PN/A --> P
- | Trial completion date, Trial primary completion date: GRIP: Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis (clinicaltrials.gov) - Mar 27, 2018
P=N/A, N=50, Active, not recruiting, Sponsor: Cartiva, Inc.
Active, not recruiting --> Completed | Phase classification: PN/A --> P Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial completion, Enrollment change: NSAID Treatment of Patients With Osteoarthritis (clinicaltrials.gov) - Mar 27, 2018
P=N/A, N=162, Completed, Sponsor: Aalborg University
Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | N=400 --> 162
- || Cimzia (certolizumab pegol) / Astellas, UCB
Phase classification: CIMAX: A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (clinicaltrials.gov) - Mar 26, 2018
P, N=680, Active, not recruiting, Sponsor: UCB Biopharma S.P.R.L.
Recruiting --> Completed | N=400 --> 162 Phase classification: P=N/A --> P
- ||| Trial completion: A Single-Center, Epidemiological Study of the Survivorship of the DePuy Sigma HP Unicompartmental Knee Prosthesis (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=300, Completed, Sponsor: Mississippi Sports Medicine and Orthopaedic Center
Phase classification: P=N/A --> P Active, not recruiting --> Completed
- || Enrollment closed, Trial completion date, Trial primary completion date: Digital Biofeedback System Versus Conventional Home-based Rehabilitation After Total Hip Replacement (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=67, Active, not recruiting, Sponsor: Sword Health, SA
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Jan 2018 --> Jul 2018
- | Trial completion date, Trial primary completion date: Sinew Acupuncture for Knee Osteoarthritis (clinicaltrials.gov) - Mar 21, 2018
P=N/A, N=86, Recruiting, Sponsor: The University of Hong Kong
Recruiting --> Active, not recruiting | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Jan 2018 --> Jul 2018 Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018
- || Enrollment closed: Rehabilitation for Total Knee Replacement: a Novel Biofeedback System Versus Conventional Home-based Rehabilitation (clinicaltrials.gov) - Mar 20, 2018
P=N/A, N=69, Active, not recruiting, Sponsor: Sword Health, SA
Trial completion date: Jun 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018 Recruiting --> Active, not recruiting
- | low-dose hrIL-2 / Beijing SL Pharma
Trial completion, Trial completion date, Trial primary completion date: A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sj (clinicaltrials.gov) - Mar 15, 2018
P2, N=60, Completed, Sponsor: Peking University People's Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial completion date: Dec 2016 --> Aug 2017 | Trial primary completion date: Jun 2016 --> Mar 2017
- ||| Jyseleca (filgotinib) / Galapagos, Gilead, SOBI
Enrollment closed: TORTUGA: A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis (clinicaltrials.gov) - Mar 12, 2018
P2, N=116, Active, not recruiting, Sponsor: Galapagos NV
Recruiting --> Completed | Trial completion date: Dec 2016 --> Aug 2017 | Trial primary completion date: Jun 2016 --> Mar 2017 Recruiting --> Active, not recruiting
- | Trial completion: Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty (clinicaltrials.gov) - Mar 9, 2018
P4, N=178, Completed, Sponsor: Columbia University
Recruiting --> Active, not recruiting Recruiting --> Completed
- || Humira (adalimumab) / AbbVie
Trial initiation date, Combination therapy: Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Chinese Rheumatoid Arthritis (RA) Patients With Inadequate Response to Methotrexate (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=60, Not yet recruiting, Sponsor: AbbVie
Recruiting --> Completed Initiation date: Nov 2017 --> Apr 2018
- | Trial completion date, Trial primary completion date: The Effectiveness of Kinesio Taping Method for Knee Osteoarthritis. (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=200, Recruiting, Sponsor: Lithuanian University of Health Sciences
Initiation date: Nov 2017 --> Apr 2018 Trial completion date: Sep 2018 --> Sep 2019 | Trial primary completion date: Sep 2017 --> Sep 2018
- | Trial completion date: SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=210, Recruiting, Sponsor: Kantonsspital Baselland Bruderholz
Trial completion date: Sep 2018 --> Sep 2019 | Trial primary completion date: Sep 2017 --> Sep 2018 Trial completion date: Dec 2017 --> Apr 2018
- | Trial completion date, Trial primary completion date: Comparison of the Femoral Prothesis-rotation in Conventional X-ray, in Axial CT Slices and 3D-reconstructed CT (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=50, Recruiting, Sponsor: Michael Tobias Hirschmann
Trial completion date: Dec 2017 --> Apr 2018 Trial completion date: Jun 2017 --> Mar 2018 | Trial primary completion date: Mar 2017 --> Feb 2018
- ||||| Cosentyx (secukinumab) / Novartis
Trial completion date, Trial initiation date, Trial primary completion date: FUTURE 3: 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis (clinicaltrials.gov) - Mar 5, 2018
P3, N=415, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Trial completion date: Jun 2017 --> Mar 2018 | Trial primary completion date: Mar 2017 --> Feb 2018 Trial completion date: Jan 2018 --> Mar 2018 | Initiation date: Apr 2014 --> Feb 2010 | Trial primary completion date: Jan 2018 --> Mar 2018
- ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei
Trial termination, Trial primary completion date: An Extension Study of KCT-0809 in Dry Eye Patients With Sj (clinicaltrials.gov) - Mar 5, 2018
P3, N=0, Terminated, Sponsor: Kissei Pharmaceutical Co., Ltd.
Trial completion date: Jan 2018 --> Mar 2018 | Initiation date: Apr 2014 --> Feb 2010 | Trial primary completion date: Jan 2018 --> Mar 2018 Recruiting --> Terminated | Trial primary completion date: Apr 2018 --> May 2017; Discontinuation of the development
- ||| Humira (adalimumab) / AbbVie
Trial completion, Trial completion date, Trial primary completion date, Real-world evidence, Real-world: Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan (clinicaltrials.gov) - Mar 5, 2018
P=N/A, N=100, Completed, Sponsor: AbbVie
Recruiting --> Terminated | Trial primary completion date: Apr 2018 --> May 2017; Discontinuation of the development Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Nov 2017 | Trial primary completion date: Dec 2017 --> Nov 2017
- | Trial primary completion date, Surgery: Bac-UP: Bacteriological Setting Before Prosthesis Implantation With One Stage Surgery in Prosthetic Joint Infection (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=100, Recruiting, Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Nov 2017 | Trial primary completion date: Dec 2017 --> Nov 2017 Trial primary completion date: Dec 2017 --> Feb 2018
- | Trial completion date, Trial primary completion date: Joint Replacement or Interpositional Arthroplasty for CMC1 Arthritis, a Prospective Trial (clinicaltrials.gov) - Mar 3, 2018
P=N/A, N=40, Active, not recruiting, Sponsor: Oslo University Hospital
Trial primary completion date: Dec 2017 --> Feb 2018 Trial completion date: Feb 2018 --> Mar 2018 | Trial primary completion date: Feb 2018 --> Mar 2018